obesity glp-1 news today Use Has More Than Quadrupled Since 2021 as Rates Continue to Show Signs of Decline Dozens of new obesity drugs

The best time to take your GLP-1 shot article also addresses timing adjustments when crossing multiple time zones

How tapering can help Tapering is the process of either gradually lowering your dose over the course of several weeks or stretching out your dose frequency, going from weekly injections to every other week, then every three weeks, and so on

The findings come amid growing concerns about pet obesity, with an estimated 60% of UK dogs now overweight or obese.[1] The news follows bio-pharma company Okava's plans to trial a weight-loss drug for dogs that mimics the effects of Ozempic, tapping into a potential $10 billion market.[2] Over half of dog owners aged 25-34 are pro "wag-ovy" Research shows that the most receptive group is dog owners aged 2534, with more than half (56%) saying they would be willing to give their pets a vet-recommended GLP-1 injection

When healthcare providers approach the treatment of obesity, considered a chronic disease, they will follow the latest treatment guidelines, which include considering GLP-1 AOMs for certain high-risk obese individuals